COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until Jun...

Full description

Bibliographic Details
Main Authors: Amir Arastehfar, Agostinho Carvalho, Frank L. van de Veerdonk, Jeffrey D. Jenks, Philipp Koehler, Robert Krause, Oliver A. Cornely, David S. Perlin, Cornelia Lass-Flörl, Martin Hoenigl
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Fungi
Subjects:
SARS COV-2
<i>Aspergillus</i>
novel coronavirus
superinfection
co-infection
risk factors
Online Access:https://www.mdpi.com/2309-608X/6/2/91

Similar Items

Similar Items